ANTI-INFECTIVE DRUGS ADVISORY COMMITTEE
October 16, 2001
Drotrecogin Alfa (ACTIVATES) [RECOMBINANT HUMAN ACTIVATED PROTEIN C (rhAPC)]
XiGRIS™, BLA #125029/0
FDA Briefing Information pdf doc
ELI LILLY AND COMPANY
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Sponsor Briefing Information pdf htm